HEADER TRANSFERASE 07-DEC-04 1WUG TITLE COMPLEX STRUCTURE OF PCAF BROMODOMAIN WITH SMALL CHEMICAL LIGAND NP1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE PCAF; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BROMODOMAIN; COMPND 5 SYNONYM: P300/CBP-ASSOCIATED FACTOR, P/CAF, HISTONE ACETYLASE PCAF; COMPND 6 EC: 2.3.1.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PCAF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET14B KEYWDS BROMODOMAIN, HISTONE-ACETYLTRANSFERASE, NMR-STRUCTURE, CHEMICAL KEYWDS 2 LIGAND, TRANSFERASE EXPDTA SOLUTION NMR AUTHOR L.ZENG,J.LI,M.MULLER,S.YAN,S.MUJTABA,C.PAN,Z.WANG,M.M.ZHOU REVDAT 3 02-MAR-22 1WUG 1 REMARK SEQADV REVDAT 2 24-FEB-09 1WUG 1 VERSN REVDAT 1 16-AUG-05 1WUG 0 JRNL AUTH L.ZENG,J.LI,M.MULLER,S.YAN,S.MUJTABA,C.PAN,Z.WANG,M.M.ZHOU JRNL TITL SELECTIVE SMALL MOLECULES BLOCKING HIV-1 TAT AND COACTIVATOR JRNL TITL 2 PCAF ASSOCIATION JRNL REF J.AM.CHEM.SOC. V. 127 2376 2005 JRNL REFN ISSN 0002-7863 JRNL PMID 15724976 JRNL DOI 10.1021/JA044885G REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WUG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000024012. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 0.5MM SAMPLE IN 100MM PHOSPHATE REMARK 210 BUFFER CONTAINING 5MM REMARK 210 PERDEUTERATED DTT REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; 3D_13C_ REMARK 210 SEPARATED_FILTERED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX500; DRX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: HNCACB, HN(CO)CACB, HCCH_TOCSY, (H)C(CO)NH_TOCSY, HNHA, REMARK 210 2D_1H_ROESY, 2D_1H_TOCSY REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 717 159.85 58.15 REMARK 500 LYS A 720 87.76 -58.03 REMARK 500 GLU A 721 128.39 -175.74 REMARK 500 ARG A 723 -87.07 54.83 REMARK 500 HIS A 742 173.16 -52.37 REMARK 500 GLU A 762 -60.87 -139.46 REMARK 500 PRO A 767 101.73 -59.91 REMARK 500 MET A 773 -76.20 -52.67 REMARK 500 ASN A 779 47.41 -105.77 REMARK 500 ARG A 780 34.79 31.67 REMARK 500 VAL A 783 53.71 -141.58 REMARK 500 LYS A 785 -78.98 -65.48 REMARK 500 ASP A 791 -71.10 -50.62 REMARK 500 PRO A 805 64.27 -66.75 REMARK 500 GLU A 806 42.58 -176.14 REMARK 500 LYS A 811 -72.66 -46.90 REMARK 500 LEU A 829 -121.06 -106.51 REMARK 500 ILE A 830 100.27 53.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NP1 A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B91 RELATED DB: PDB REMARK 900 STRUCTURE AND LIGAND OF A HISTONE ACETYLTRANSFERASE BROMODOMAIN REMARK 900 RELATED ID: 1JM4 RELATED DB: PDB REMARK 900 RECOGNITION OF HIV-1 TAT BY PCAF BROMODOMAIN REMARK 900 RELATED ID: 1WUM RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH SMALL CHEMICAL LIGAND NP2 DBREF 1WUG A 719 832 UNP Q92831 PCAF_HUMAN 719 832 SEQADV 1WUG GLY A 715 UNP Q92831 EXPRESSION TAG SEQADV 1WUG SER A 716 UNP Q92831 EXPRESSION TAG SEQADV 1WUG HIS A 717 UNP Q92831 EXPRESSION TAG SEQADV 1WUG MET A 718 UNP Q92831 EXPRESSION TAG SEQADV 1WUG PRO A 804 UNP Q92831 ALA 804 CONFLICT SEQADV 1WUG PRO A 805 UNP Q92831 ALA 805 CONFLICT SEQRES 1 A 118 GLY SER HIS MET SER LYS GLU PRO ARG ASP PRO ASP GLN SEQRES 2 A 118 LEU TYR SER THR LEU LYS SER ILE LEU GLN GLN VAL LYS SEQRES 3 A 118 SER HIS GLN SER ALA TRP PRO PHE MET GLU PRO VAL LYS SEQRES 4 A 118 ARG THR GLU ALA PRO GLY TYR TYR GLU VAL ILE ARG PHE SEQRES 5 A 118 PRO MET ASP LEU LYS THR MET SER GLU ARG LEU LYS ASN SEQRES 6 A 118 ARG TYR TYR VAL SER LYS LYS LEU PHE MET ALA ASP LEU SEQRES 7 A 118 GLN ARG VAL PHE THR ASN CYS LYS GLU TYR ASN PRO PRO SEQRES 8 A 118 GLU SER GLU TYR TYR LYS CYS ALA ASN ILE LEU GLU LYS SEQRES 9 A 118 PHE PHE PHE SER LYS ILE LYS GLU ALA GLY LEU ILE ASP SEQRES 10 A 118 LYS HET NP1 A 201 30 HETNAM NP1 N-(3-AMINOPROPYL)-4-METHYL-2-NITROBENZENAMINE FORMUL 2 NP1 C10 H15 N3 O2 HELIX 1 1 ASP A 724 HIS A 742 1 19 HELIX 2 2 ALA A 745 GLU A 750 1 6 HELIX 3 3 ASP A 769 ASN A 779 1 11 HELIX 4 4 SER A 784 ASN A 803 1 20 HELIX 5 5 SER A 807 GLY A 828 1 22 SITE 1 AC1 7 GLU A 750 VAL A 752 GLU A 756 ALA A 757 SITE 2 AC1 7 PRO A 758 TYR A 802 TYR A 809 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000